B1DX34 Stock Overview
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Becton, Dickinson and Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$241.50 |
| 52 Week High | US$272.01 |
| 52 Week Low | US$214.70 |
| Beta | 0.46 |
| 1 Month Change | -1.25% |
| 3 Month Change | 4.26% |
| 1 Year Change | -6.93% |
| 3 Year Change | -11.54% |
| 5 Year Change | n/a |
| Change since IPO | 2.55% |
Recent News & Updates
Recent updates
Shareholder Returns
| B1DX34 | BR Medical Equipment | BR Market | |
|---|---|---|---|
| 7D | 0% | 0.5% | 0.9% |
| 1Y | -6.9% | -1.8% | 15.2% |
Return vs Industry: B1DX34 underperformed the BR Medical Equipment industry which returned -1.7% over the past year.
Return vs Market: B1DX34 underperformed the BR Market which returned 14.6% over the past year.
Price Volatility
| B1DX34 volatility | |
|---|---|
| B1DX34 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.6% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in BR Market | 8.9% |
| 10% least volatile stocks in BR Market | 2.2% |
Stable Share Price: B1DX34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine B1DX34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1897 | 70,000 | Tom Polen | www.bd.com |
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems.
Becton, Dickinson and Company Fundamentals Summary
| B1DX34 fundamental statistics | |
|---|---|
| Market cap | R$354.87b |
| Earnings (TTM) | R$6.97b |
| Revenue (TTM) | R$100.76b |
50.9x
P/E Ratio3.5x
P/S RatioIs B1DX34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| B1DX34 income statement (TTM) | |
|---|---|
| Revenue | US$19.72b |
| Cost of Revenue | US$10.93b |
| Gross Profit | US$8.79b |
| Other Expenses | US$7.42b |
| Earnings | US$1.36b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.72 |
| Gross Margin | 44.56% |
| Net Profit Margin | 6.92% |
| Debt/Equity Ratio | 70.2% |
How did B1DX34 perform over the long term?
See historical performance and comparison